BTIG analyst Mark Massaro lowered the firm’s price target on Ginkgo Bioworks (DNA) to $6 from $7 and keeps a Sell rating on the shares ...
Revenue exceeded analyst estimates by 98%. Earnings per share (EPS) also surpassed analyst estimates by 67%. Looking ahead, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback